Contents
Scroll to:
Coronary Artery Ectasia prevalence and factors associated with ectasia in patients undergoing coronary angiography: An observational comparison analytic study
https://doi.org/10.15829/1728-8800-2026-4656
EDN: XDXEHC
Abstract
Aim. To determine the prevalence and risk factors of coronary artery ectasia (CAE), as well as the distribution of ectasia among the coronary vessels.
Material and methods. An observational comparison analytic study was conducted in two cardiac centers in Iraq from February 2020 to February 2021, involving 263 patients who underwent coronary angiography. Clinical data and cardiovascular factors were analyzed to identify associations with CAE using logistic regression.
Results. CAE was detected in 14.8% of the patients, a prevalence higher than that reported in similar studies in the region. Significant risk factors for CAE included male sex, older age, history of ischemic heart disease (IHD), family history of IHD, smoking, diabetes mellitus type-II, arterial hypertension, and hypercholesterolemia. Among the affected vessels, the right coronary artery (RCA) was the most commonly involved, followed by the left circumflex artery (LCX) and left anterior descending artery (LAD).
Conclusion. The prevalence of CAE in the Basrah/Iraq population was higher than in many other countries. CAE appears to be a multifactorial condition caused by traditional cardiovascular factors, with the RCA being the most frequently affected coronary vessel.
For citations:
Nassir H.A., Mohammed A.I., Swaid H.A. Coronary Artery Ectasia prevalence and factors associated with ectasia in patients undergoing coronary angiography: An observational comparison analytic study. Cardiovascular Therapy and Prevention. 2026;25(7):4656. https://doi.org/10.15829/1728-8800-2026-4656. EDN: XDXEHC
Introduction
Coronary artery ectasia (CAE) is a relatively rare coronary artery diseases (CAD) variant. It is characterized by abnormal portion enlargement or the entire length of a coronary artery (CA), measuring at least 1.5 times wider than a nearby normal segment. Ectasia is most often associated with atherosclerotic CAD [1][2]. The incidence of CAE varies significantly, ranging from 0.3 to 12%, as observed in autopsy findings and diagnostic techniques like coronary angiography or multi-detector computed tomography [3]. This variability largely depends on the methods used and the specific population studied [4].
There are several approaches to defining the CAE based on its severity and distribution. Various definitions have been proposed depending on the study methodology. Yang X, et al. [5] described ectasia as a CA segment greater than that of the adjacent normal segment. Meanwhile, Sheikh AS, et al. [6] developed a classification system to categorize CAE based on the extent of arterial involvement: Type I (diffuse in two to three vessels), Type II (diffuse in one vessel and localized in another), Type III (diffuse in a single vessel), and Type IV (localized or segmental dilatation).
In adults, most cases of CAE and CA aneurysms are associated with atherosclerosis or result from vessel wall damage following coronary interventions such as stent placement, balloon angioplasty, and/or atherectomy [7]. In contrast, in early age groups, vasculitic conditions, particularly Kawasaki disease, are more frequent. Less commonly, coronary aneurysms may arise because of factors such as cocaine use or systemic infections [8]. Evidence also suggests a genetic predisposition to the development of both CAE and aneurysms [9].
Aneurysmal dilation often leads to turbulent (sluggish) coronary blood flow, increasing the risk of typical exertional myocardial infarction (MI) and angina irrespective of the associated stenosis. Individuals with isolated CAE — representing ~15% of cases — tend to have a relatively more benign prognosis. However, ~39% of these individuals still exhibit signs of previous MI [10].
Earlier research, which highlighted considerable flow disturbances in ectatic segments, proposed chronic anticoagulation as a primary treatment approach. However, this therapy has not been thoroughly tested in prospective studies; therefore, it cannot be recommended without further supporting evidence from future research. When CAE coexists with obstructive CAD, its prognosis and management are typically aligned with those of CAD alone. However, in cases of isolated CAE, prognosis tends to be more favorable, and antiplatelet therapy remains the cornerstone of treatment [11].
Evidence suggests that CAE may not be as benign as previously believed. The individuals with CA aneurysms presented with a significantly greater 5-year mortality rate, with an adjusted hazard ratio of 1.56 (95% confidence interval (CI): 1.01-2.41) [12]. Another study reported that 54% of patients with coronary aneurysms detected via computed tomography imaging experienced high adverse cardiovascular events over a median following-up of 4 years [13].
Doi T, et al. reported that CAE was independently associated with significantly increased risks of cardiac death (3-fold increase; p=0.004) and non-fatal MI (5-fold increase; p<0.001) [14].
Due to limited evidence, long-term anticoagulation therapy is typically reserved for high-risk patients, such as those with multivessel ectasia or those experiencing recurrent thrombotic events despite being on dual antiplatelet therapy. The common coexistence of CAE with obstructive lesions, coupled with the documented risk of MI in some cases, justifies the routine use of aspirin in all CAE patients [15].
Data on percutaneous coronary intervention in the context of incidental coronary aneurysms remain limited, mostly derived from small case series [16]. In acute coronary syndrome, percutaneous coronary intervention involving aneurysmal segments is associated with poor prognosis, including least procedural success, greater rates of no-re-flow and distal embolization, increased risk of stent thrombosis, need for frequent revascularization, and greater long-term mortality [17].
The aim of this study was to assess CAE prevalence among subjects who underwent coronary angiography and intervention, as well as the possible factors associated with ectasia. Anatomical distribution of vessels involved.
Methods
Study design and setting. An observational comparison analytic study was conducted in Ibn Al-Baitar and Al-Nasirya cardiac centers between February 2020 and February 2021, involving 263 patients who underwent elective and emergency coronary angiography.
Ethical approval. The Medical Ethical Committee of The Department of Medicine approved this study (no. 398 on 20-01-2019).
Coronary angiography intervention. Coronary angiography was performed based on clinical indications, such as a history of angina, prior or acute MI, or positive results from noninvasive diagnostic testing. Every patient underwent an ECG performed as a routine evaluation, and coronary angiography was performed using Philips devices in both centers, using (Seldinger) technique with the femoral or radial approach. The findings were interrupted by two senior interventional cardiologists during the procedure for every case [18][19].
Data collection and excluding criteria. Patient data were collected by using a study-specific questionnaire. Individuals with congenital or valvular heart disease as well as cardiomyopathies were excluded from the study, as these conditions are more commonly associated with congenital forms of ectasia and arterial dilatation, according to previous reports.
Statistical analysis. Data were analyzed using the Statistical Package for the Social Sciences (SPSS) version-22. Categorical variables are presented as frequencies and percentages, and the associations between them were measured using Pearson’s test. Logistic regression is a robust method for evaluating the relationship between one or more predictor variables (continuous or categorical) and the presence or absence of CAE. It estimates the odds ratio for each factor, and statistical significance is assessed through 95% CI. Continuous parametric data were compared between study groups using an independent two-tailed t-test with significant statistical p-value <0.05.
Results
In total, 263 cases were included in this study who underwent coronary angiography, 39 patients had CAE in one or more vessels, while 224 were non-ectatic (did not have ectasia), with age (mean) of the non-ectatic group was (62.1±9) years. The age (mean) of the ectasia group was greater, since CAE was more common in the older age group. Approximately, the non-ectatic group males to female ratio was 1.52:1, whereas in the ectatic group, it was 2.55:1. The non-ectatic group included patients with diabetes mellitus (DM) type-II greater by 3-folds than in the ectatic group. Regarding smoking habits, the non-ectatic group had active smoker cases more than in the ectatic group by 3-times. The non-ectatic group had cases with positive ischemic heart disease (IHD) family history more than the ectatic group, by 3-folds. History of IHD was presented more in the non-ectatic group than the ectatic group by 4-folds. Among healthy people, hypercholesterolemia was almost 3 times more common than in patients with ectasia (table 1).
Table 1
Characteristic distribution of patients in the study
Variables | Non-ectatic group (n=224) | Ectasia group (n=39) | p | |
n (%) | ||||
Sex | Male | 135 (60.2) | 28 (71.8) | 0.004 |
Female | 89 (39.8) | 11 (28.2) | ||
Age, years | 62.1±9 | 66±10 | 0.05 | |
DM type-II | 104 (46.4) | 33 (84.6) | 0.001 | |
HTN | 120 (53.5) | 31 (79.4) | 0.02 | |
Smoking | Yes | 89 (39.8) | 30 (76.9) | 0.01 |
Ex-smoker | 135 (60.2) | 9 (23.1) | ||
Family history (positive) | 93 (37) | 33 (84.6) | 0.033 | |
Previous IHD | 125 (54) | 29 (74.4) | 0.049 | |
Hypercholesterolemia | 108 (47.7) | 35 (89.7) | 0.001 | |
Hypertriglycerimia | 103 (45.9) | 17 (43.6) | 0.461 | |
CAE | 224 (85.2) | 39 (14.8) | 0.03 | |
Note: CAE — coronary artery ectasia, DM — diabetes mellitus, HTN — hypertension.
The logistic regression analysis identified several significant factors. Increased age was significantly associated with elevated ectasia rate. DM, hypertension (HTN), smoking history, and IHD positive family history were also strong and statistically significant factors. Notably, a previous history of IHD showed the strongest association, indicating that patients with prior IHD were substantially more likely to develop the ectasia (table 2).
Table 2
Logistic regression analysis of variables
Variables | Score | OR (95% CI) | p |
Age, years | 7.514 | 3.25 (1.455-10.801) | 0.006 |
DM type-II | 19.409 | 10.65 (5.308-20.977) | <0.001 |
HTN | 33.964 | 12.87 (11.094-45.218) | <0.001 |
Smoking history | 28.469 | 11.84 (10.532-30.471) | <0.001 |
Family history of IHD | 35.260 | 20.61 (19.472-50.244) | <0.001 |
History of IHD | 122.66 | 50.73 (58.124-200.417) | <0.001 |
Hypercholesterolemia | 22.311 | 9.36 (8.555-35.198) | <0.001 |
Note: CI — confidence interval, DM — diabetes mellitus, IHD — ischemic heart disease, HTN — hypertension, OR — odds ratio.
Among the study participants, involvement of the coronary arteries was most frequently observed in the right coronary artery (RCA), which was affected in 25 patients (64.1%). The left circumflex artery was involved in 17 patients (43.6%), while the anterior descending artery (LAD) was affected in 16 patients (41%). These findings indicate that RCA involvement was the most common among the coronary vessels assessed.
Discussion
In our study, CAE was more common (14.8%) than its prevalence in similar studies done across the world [20]. This high prevalence may be attributed to the elevated CAD prevalence and atherosclerosis conditions in the Middle East or may be attributed to the increased genetic predisposition to the development of CAE.
Ectatic patients were mostly over 40-years-old (65 to 70 years). CAE was predominant in males in this study. This finding is supported by previous studies that mentioned man dominance for CAE, with an M:F ratio of 2:1 [21]. However, this ratio was higher in a large study performed in Singapore (3:1), although the incidence of ectasia was less than that in this study [4]. This may be attributed to the fact that no exclusion criteria were mentioned in the study, while in our study, we mentioned valvular heart disease, congenital, and cardiomyopathy disease as exclusion criteria.
Overall, logistic regression in this study provided a structured and statistically rigorous approach to evaluate how each factor contributes to disease likelihood, highlighting the factor associated with ectasia such as prior IHD family history, HTN and DM type-II. A meta-analysis showed that DM was present in cases with CAE in percentage around 8-33% and suggested DM as a protective against the development of CAE [22], while the incidence of DM in our study was higher at 84.6%). This may be due to the high prevalence of DM type-II in middle-aged people [23]. These results are supported by previous studies in our region [24].
In this study, a significant majority of patients with CAE — 79.4%) were found to have HTN, and 76.9% were current smokers. These factors for CAD align with findings from other studies, which have also shown a strong association between HTN, smoking, and CAE [25]. A significant number (74.4%) of cases had a positive history of IHD or presented with acute angina, these results come in line with the results presented by Nyamu P, et al. [25] and Demopoulos VP, et al. [26].
These observations may introduce ectasia as a factor for IHD and sudden cardiac death due to slow flow, coronary spasm, coronary dissection, and CA thrombosis [27]. We found that approximately 89.7% of cases had hypercholesterolemia on statin therapy. Our results revealed a significant correlation between hypercholesterolemia and ectasia. Many studies have also highlighted the prevalence of hypercholesterolemia among patients with CAE, with rates reported as 63% in Singapore, 59% in Saudi Arabia [24], and 41.7% in Iran [20]. These findings, including those from our study, are consistent with those of other studies that have shown a clear association between hypercholesterolemia and the presence of CAE, showing that this lipid disorder was very common in patients with coronary ectasia. However, patients with hypertriglyceridemia showed no statistical significance in terms of CAE, which is supported by many studies [28-32].
Consistent with previous studies, the RCA was the most frequently affected vessel in our study. However, Nyamu et al. found that the LAD was the most commonly affected vessel [25]. They also observed that ectasia in the LAD typically presented as discrete, whereas the RCA showed a more diffuse pattern of ectasia, a finding also noted in Demopoulos et al.’s study [26].
This study has several limitations that should be acknowledged. First, the study was conducted in two cardiac centers only, which may restrict the generalizability of the findings to the wider population. Second, angiographic assessment was used to diagnose CAE without intravascular imaging modalities, which could provide more precise measurements of ectatic segments. In addition, some potential confounding factors, such as inflammatory markers, lipid subfractions, or genetic predispositions, were not evaluated. Finally, the relatively small sample size may have limited the power to detect weaker associations. Despite these limitations, the study provides valuable insight into the prevalence and factors of CAE in the Iraqi population.
Conclusion
The CAE prevalence in the two Iraqi cardiac centers was higher than the expected level in the Middle East. The distribution of common CHD factors was the most prevalent in CAE subjects. Except for an increase in triglyceride levels, there was no statistical significance in this study. Future studies should aim to include larger, multicenter cohorts to improve the generalizability of findings and to better represent different regions and populations. The use of advanced imaging techniques such as intravascular ultrasound, optical coherence tomography, or coronary computed tomography angiography is recommended to provide a more accurate assessment of CAE morphology and extent. In addition, prospective cohort studies are needed to clarify the causal relationship between identified factors and CAE development. Further research should also explore the pathophysiological mechanisms underlying CAE, including the role of inflammation, endothelial dysfunction, and genetic susceptibility. Finally, studies assessing the long-term clinical factors associated with ectasia and optimal management strategies for patients with CAE would be valuable in guiding prevention and treatment approaches.
Relationships and Activities: none.
References
1. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American College of Radiology; American Stroke Association; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of Thoracic Surgeons; Society for Vascular Medicine. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. J Am Coll Cardiol. 2010 Apr 6;55(14):e27-e129. doi: 10.1016/j.jacc.2010.02.015. Erratum in: J Am Coll Cardiol. 2013 Sep 10;62(11):1039-40. PMID: 20359588.
2. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB 3rd, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV, Anderson JL; American College of Cardiology Foundation/American Heart Association Task Force. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012 Dec 18;126(25):e354-471. doi: 10.1161/CIR.0b013e318277d6a0. Epub 2012 Nov 19. Erratum in: Circulation. 2014 Apr 22;129(16):e463. PMID: 23166211.
3. Mavrogeni S. Coronary artery ectasia: from diagnosis to treatment. Hellenic J Cardiol. 2010 Mar-Apr;51(2):158-63. PMID: 20378518.
4. Lin C-T, Chen C-W, Lin T-K, Lin C-L. Coronary Artery Ectasia. Tzu Chi Medical Journal, 2008;20:270-274. http://dx.doi.org/10.1016/S1016-3190(08)60049-X
5. Lam CS, Ho KT. Coronary artery ectasia: a ten-year experience in a tertiary hospital in Singapore. Ann Acad Med Singap. 2004 Jul;33(4):419-22. PMID: 15329751.
6. Yang X, Zong Y, Zhang Z, Zhao Y, Gao X, Zhang J, Hou Q, Li R, Xiao B. Identification of Potential Abnormal Methylation-Modified Genes in Coronary Artery Ectasia. Int J Genomics. 2023 Aug 26;2023:4969605. doi: 10.1155/2023/4969605. PMID: 37662558; PMCID: PMC10474963.
7. Sheikh AS, Hailan A, Kinnaird T, Choudhury A, Smith D. Coronary Artery Aneurysm: Evaluation, Prognosis, and Proposed Treatment Strategies. Heart Views. 2019 Jul-Sep;20(3):101-108. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_1_19. PMID: 31620255; PMCID: PMC6791093.
8. Sheikh AS, Hailan A, Kinnaird T, Choudhury A, Smith D. Coronary Artery Aneurysm: Evaluation, Prognosis, and Proposed Treatment Strategies. Heart Views. 2019 Jul-Sep;20(3):101-108. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_1_19. PMID: 31620255; PMCID: PMC6791093.
9. Kawsara A, Núñez Gil IJ, Alqahtani F, Moreland J, Rihal CS, Alkhouli M. Management of Coronary Artery Aneurysms. JACC Cardiovasc Interv. 2018 Jul 9;11(13):1211-1223. doi: 10.1016/j.jcin.2018.02.041. PMID: 29976357.
10. Bavry AA, Chiu JH, Jefferson BK, Karha J, Bhatt DL, Ellis SG, Whitlow PL. Development of coronary aneurysm after drug-eluting stent implantation. Ann Intern Med. 2007 Feb 6;146(3):230-2. doi: 10.7326/0003-4819-146-3-200702060-00146. PMID: 17283357.
11. Baker DW, Whitehead NJ, Barlow M. Mycotic Coronary Aneurysms. Heart Lung Circ. 2020 Jan;29(1):128-136. doi: 10.1016/j.hlc.2018.12.004. Epub 2018 Dec 19. PMID: 30686642.
12. Abou Sherif S, Ozden Tok O, Taşköylü Ö, Goktekin O, Kilic ID. Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment. Front Cardiovasc Med. 2017 May 5;4:24. doi: 10.3389/fcvm.2017.00024. PMID: 28529940; PMCID: PMC5418231.
13. Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum. 2009 Aug 15;61(8):1121-9. doi: 10.1002/art.24695. PMID: 19644909.
14. Baman TS, Cole JH, Devireddy CM, Sperling LS. Risk factors and outcomes in patients with coronary artery aneurysms. Am J Cardiol. 2004 Jun 15;93(12):1549-51. doi: 10.1016/j.amjcard.2004.03.011. PMID: 15194034.
15. Warisawa T, Naganuma T, Tomizawa N, Fujino Y, Ishiguro H, Tahara S, Kurita N, Nojo T, Nakamura S, Nakamura S. High prevalence of coronary artery events and non-coronary events in patients with coronary artery aneurysm in the observational group. Int J Cardiol Heart Vasc. 2015 Oct 22;10:29-31. doi: 10.1016/j.ijcha.2015.10.005. PMID: 28616512; PMCID: PMC5441364.
16. Joo HJ, Woong Yu C, Choi R, Park J, Lee HJ, Kim JS, Choi YJ, Park JH, Hong SJ, Lim DS. Clinical outcomes of patients with coronary artery aneurysm after the first generation drug-eluting stent implantation. Catheter Cardiovasc Interv. 2018 Sep 1;92(3):E235-E245. doi: 10.1002/ccd.27429. Epub 2017 Nov 22. PMID: 29164770.
17. Doi T, Kataoka Y, Noguchi T, Shibata T, Nakashima T, Kawakami S, Nakao K, Fujino M, Nagai T, Kanaya T, Tahara Y, Asaumi Y, Tsuda E, Nakai M, Nishimura K, Anzai T, Kusano K, Shimokawa H, Goto Y, Yasuda S. Coronary Artery Ectasia Predicts Future Cardiac Events in Patients With Acute Myocardial Infarction. Arterioscler Thromb Vasc Biol. 2017 Dec;37(12):2350-2355. doi: 10.1161/ATVBAHA.117.309683. Epub 2017 Oct 19. PMID: 29051141.
18. Núñez-Gil IJ, Terol B, Feltes G, Nombela-Franco L, Salinas P, Escaned J, Jiménez-Quevedo P, Gonzalo N, Vivas D, Bautista D, Macaya C, Fernández-Ortiz A. Coronary aneurysms in the acute patient: Incidence, characterization and long-term management results. Cardiovasc Revasc Med. 2018 Jul-Aug;19(5 Pt B):589-596. doi: 10.1016/j.carrev.2017.12.003. Epub 2017 Dec 6. PMID: 29276176.
19. Iannopollo G, Ferlini M, Koziński M, Ormezzano MF, Crimi G, Lanfranchi L, Camporotondo R, Visconti LO, De Ferrari GM, De Servi S. Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI. J Am Coll Cardiol. 2017 Jun 20;69(24):3006-3007. doi: 10.1016/j.jacc.2017.04.030. PMID: 28619200.
20. Araiza-Garaygordobil D, Gopar-Nieto R, Sierra-Lara Martínez D, Belderrain-Morales N, Sarabia-Chao V, Alfaro-Ponce DL, Ontiveros-Mercado H, Mendoza-García S, Altamirano-Castillo A, Martinez-Amezcua P, Cabello-López A, Briseño-De la Cruz JL, Ruiz-Beltrán M, Martínez-Ríos MA, Piña-Reyna Y, Gonzalez-Pacheco H, Arias-Mendoza A. Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy Plus Oral Anticoagulation in Patients with Acute Coronary Syndrome and Coronary Artery Ectasia: Design and Rationale of OVER-TIME Randomized Clinical Trial. High Blood Press Cardiovasc Prev. 2022 Sep;29(5):463-468. doi: 10.1007/s40292-022-00535-4. Epub 2022 Jul 29. PMID: 35904750.
21. Ovalı C, Morrad B. Associations between coronary artery disease, aneurysm and ectasia. Kardiochir Torakochirurgia Pol. 2017 Sep;14(3):158-163. doi: 10.5114/kitp.2017.70276. Epub 2017 Sep 30. PMID: 29181042; PMCID: PMC5701588.
22. Ipek G, Gungor B, Karatas MB, Onuk T, Keskin M, Tanik O, Hayiroglu MI, Oz A, Borklu EB, Bolca O. Risk factors and outcomes in patients with ectatic infarct-related artery who underwent primary percutaneous coronary intervention after ST elevated myocardial infarction. Catheter Cardiovasc Interv. 2016 Nov;88(5):748-753. doi: 10.1002/ccd.26553. Epub 2016 May 3. PMID: 27143640.
23. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun;71(6):1269-1324. doi: 10.1161/HYP.0000000000000066. Epub 2017 Nov 13. Erratum in: Hypertension. 2018 Jun;71(6):e136-e139. doi: 10.1161/HYP.0000000000000075. Erratum in: Hypertension. 2018 Sep;72(3):e33. doi: 10.1161/HYP.0000000000000080. PMID: 29133354.
24. Grundy S, Stone N, Bailey A, et al. 2018AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol. 2019 Jun, 73 (24) e285– e350.https://doi.org/10.1016/j.jacc.2018.11.003
25. Jafari J, Daum A, Hamed JA, Osherov A, Orlov Y, Yosefy C, Gallego-Colon E. Low High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia. Biomedicines. 2019 Oct 7;7(4):79. doi: 10.3390/biomedicines7040079. PMID: 31591337; PMCID: PMC6966440.
26. Amirzadegan AR, Davoodi G, Soleimani A, Lotfi Tokaldany M, Hakki Kazazi E, Shabpiray H, Khorsand Askari M. Association between Traditional Risk Factors and Coronary Artery Ectasia: A Study on 10057 Angiographic Procedures among Iranian Population. J Tehran Heart Cent. 2014 Jan 12;9(1):27-32. PMID: 25561967; PMCID: PMC4277788.
27. Giannoglou GD, Antoniadis AP, Chatzizisis YS, Damvopoulou E, Parcharidis GE, Louridas GE. Prevalence of ectasia in human coronary arteries in patients in northern Greece referred for coronary angiography. Am J Cardiol. 2006 Aug 1;98(3):314-8. doi: 10.1016/j.amjcard.2006.02.034. Epub 2006 Jun 6. PMID: 16860015.
28. Huang QJ, Liu J, Chen MH, Li JJ. Relation of diabetes to coronary artery ectasia: A meta-analysis study. Anadolu Kardiyol Derg. 2014 Jun;14(4):322-7. doi: 10.5152/akd.2014.5327. Epub 2014 May 2. PMID: 24818774.
29. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS, Arafah MR, Khalil MZ, Khan NB, Al-Khadra A, Al-Marzouki K, Nouh MS, Abdullah M, Attas O, Al-Shahid MS, Al-Mobeireek A. Diabetes mellitus in Saudi Arabia. Saudi Med J. 2004 Nov;25(11):1603-10. PMID: 15573186.
30. Mansour AA, Al-Maliky AA, Kasem B, Jabar A, Mosbeh KA. Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq. Diabetes Metab Syndr Obes. 2014 May 2;7:139-44. doi: 10.2147/DMSO.S59652. PMID: 24833912; PMCID: PMC4014373.
31. Almansori MA, Elsayed HA. CA ectasia - A sample from Saudi Arabia. J Saudi Heart Assoc. 2015 Jul;27(3):160-3. doi: 10.1016/j.jsha.2015.03.005. Epub 2015 Mar 30. PMID: 26136630; PMCID: PMC4481509.
32. Zhongwei Cheng, Yingxian Liu, Shuyang Zhang, et al. Clinical characteristics and coronary features of coronary ectasia and aneurysm in China. World J Cardiovasc Dis.2013;3:18–21.
33. Malviya A, Jha PK, Mishra A. Isolated coronary artery ectasia: Clinical, angiographic, and follow up characteristics. Indian Heart J. 2017 Sep-Oct;69(5):619-623. doi: 10.1016/j.ihj.2016.12.017. Epub 2017 Jan 22. PMID: 29054186; PMCID: PMC5650589.
34. Nyamu P, Ajit MS, Joseph PK, Venkitachalam L, Sugirtham NA. The prevalence and clinical profile of angiographic coronary ectasia. Asian Cardiovasc Thorac Ann. 2003 Jun;11(2):122-6. doi: 10.1177/021849230301100207. PMID: 12878558.
35. Demopoulos VP, Olympios CD, Fakiolas CN, Pissimissis EG, Economides NM, Adamopoulou E, Foussas SG, Cokkinos DV. The natural history of aneurysmal coronary artery disease. Heart. 1997 Aug;78(2):136-41. doi: 10.1136/hrt.78.2.136. PMID: 9326986; PMCID: PMC484892.
36. Aboeata AS, Sontineni SP, Alla VM, Esterbrooks DJ. Coronary artery ectasia: current concepts and interventions. Front Biosci (Elite Ed). 2012 Jan 1;4(1):300-10. doi: 10.2741/377. PMID: 22201872.
37. Fariba F, Moradi M, Arabi A, Ghaderi B. Prevalence of CA Ectasia with Atherosclerosis and Associated Risk Factors in the West of Iran: A Cross-Sectional Study. J Res Health Sci. 2016 Winter;16(1):22-5. PMID: 27061992; PMCID: PMC7189084.
38. Qin Y, Tang C, Ma C, Yan G. Risk factors for CA ectasia and the relationship between hyperlipidemia and CA ectasia. Coron Artery Dis. 2019 May;30(3):211-215. doi: 10.1097/MCA.0000000000000709. PMID: 30741741.
About the Authors
Hayder Abdulateef Zghair Nassir
College of Medicine, University of Basrah
Iraq
Iraq
F.I.C.M.S., C.A.B.M (Cardio.), Associate Professor, Department of internal Medicine.
Al-Baradhyiah, Kornish St. 13, 61007, Basrah
Ahmed Qasim Ibrahim Mohammed
Basra Health Directorate
Iraq
Iraq
Lecturer, Department of Medicine.
Manawi St. 20, 61009, Basrah
Hassan Abdulrazzaq Swaid
Basra Health Directorate
Iraq
Iraq
Lecturer, Department of Medicine.
Manawi St. 20, 61009, Basrah
What is already known about the subject?
- Coronary artery ectasia (CAE) is a rare cardiovascular condition (abnormal dilatation of the coronary arteries), with reported prevalence ranging from 1 to 5% of patients undergoing coronary angiography.
- The majority of adult cases are atherosclerotic in origin, although congenital and inflammatory causes also exist.
- Altered blood flow in ectatic segments can cause turbulence, stasis, and thrombus formation, increasing the risk of myocardial ischemia or infarction even without obstructive lesions.
What might this study add?
- The study reinforces the traditional cardiovascular factors like diabetes, hypertension, smoking, hypercholesterolemia, and family history of ischemic heart disease are strongly associated with CAE.
- This study helps refine which metabolic factors truly contribute to ectasia, preventing overestimation of risk from unrelated parameters.
- Recognizing CAE in patients may help anticipate complications (e.g., thrombus formation, myocardial ischemia) and guide management.
Review
For citations:
Nassir H.A., Mohammed A.I., Swaid H.A. Coronary Artery Ectasia prevalence and factors associated with ectasia in patients undergoing coronary angiography: An observational comparison analytic study. Cardiovascular Therapy and Prevention. 2026;25(7):4656. https://doi.org/10.15829/1728-8800-2026-4656. EDN: XDXEHC
Views:
411
JATS XML
Email this article 
